Revalesio

About:

Revalesio develops therapeutics for the treatment of inflammatory diseases.

Twitter/X: revalesio

Description:

Revalesio Corporation, a biotechnology company, develops therapeutics for the treatment of inflammatory diseases. It offers respiratory, cardiovascular, neuroscience, orthopedic, wound care, and oncology products. The company was formerly known as Microdiffusion, Inc. and changed its name to Revalesio Corporation in August 2007. Revalesio Corporation was founded in 2000 and is based in Tacoma, Washington.

Total Funding Amount:

$38.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tacoma, Washington, United States

Founded Date:

2000-01-01

Contact Email:

contact(AT)revalesio.com

Founders:

Eric Russell

Number of Employees:

11-50

Last Funding Date:

2016-07-05

IPO Status:

Private

Industries: